Since its inception in 1998, the Beckley Foundation has focused on using psychoactive substances as tools to alter cognitive function. By studying the impacts psychoactive substances, like MDMA, have on the brain, we gain a clearer understanding of brain flow, neural activity, and how the mind works.

The Beckley Foundation brain-imaging studies using MDMA (ecstasy) have provided a neurophysiological explanation of why MDMA can be a valuable aid in psychotherapy. Most notable, the Beckley Foundation’s groundbreaking research showed that MDMA can be help war veterans suffering from post-traumatic stress disorder (PTSD). This research sheds light on the mechanisms by which MDMA allows traumatic experiences to be recalled, and dealt with, without an overwhelming emotional response. This, and a complete list of Beckley Foundation studies involving MDMA can be accessed by clicking here.

Thumbnail image for Psychedelic Science Conference 2013

Psychedelic Science Conference 2013

April 26, 2013 Beckley in the Media

The Psychedelic Science conference, co-hosted by the Beckley Foundation, brought together researchers from around the world to discuss research, clinical trials, and medical discoveries involving psychedelic substances. Amanda Feilding presented the results of the Beckley Foundation research programme, including our recent investigations into psilocybin and MDMA.

Continue Reading →

MDMA may help treat depression and PTSD, Channel 4 study suggests

September 28, 2012 Beckley in the Media

Research hints at therapeutic uses for MDMA – but the taboo surrounding psychoactive drugs prevents similar studies by Amanda Feilding Click here for original Article in The Guardian I was amused by Conal Urquhart’s description in the Observer of the novelist Lionel Shriver being sucked into an MRI brain scanner “that resembles a giant washing machine”. I see […]

Continue Reading →

Channel 4 to screen volunteers taking the drug Ecstasy

July 20, 2012 Beckley Science in the Media

An experiment in which volunteers take the dance drug Ecstasy is to be screened on Channel 4 in a first for British television. This research forms part of the Beckley Foundation/Imperial College Psychedelic Research Programme: a collaboration between Amanda Fielding and Prof. David Nutt’s team at Imperial College. July 2012 Click here for original article […]

Continue Reading →
Thumbnail image for Scientists’ agony over ecstasy

Scientists’ agony over ecstasy

July 19, 2012 MDMA

Until science can freely study drugs like MDMA, their great therapeutic potential will stay untapped David Nutt There are some goals most scientists share when they embark on their career: to advance your field, to make discoveries, to innovate and to increase knowledge. All of which help towards the scientist’s ultimate aim: to improve quality […]

Continue Reading →

MDMA Turns 100 Years Old, Still Faces Stereotypes. Part 2

June 29, 2012 MDMA

Click here for original article Care2: How is MDMA being used to treat those suffering from PTSD? Burge: “It’s not the MDMA alone, but how it is used in combination with psychotherapy, that can help people suffering from PTSD. MDMA can actually increase the effectiveness of psychotherapy, allowing people with PTSD to discuss their painful memories […]

Continue Reading →

MDMA Turns 100 Years Old, Still Faces Stereotypes

June 29, 2012 MDMA

JUNE 2012 Beth Buczynski On an unknown date in 1912, Dr. Anton Köllisch of the Merck Pharmaceutical Company was working on creating a new blood-clotting medication. During his research, he discovered a string of new chemicals, one of which was named 3,4-methylenedioxy-N-methylamphetamine, or MDMA. At the time, neither Dr. Köllisch or Merck were aware of the drug’s psychoactive effects, […]

Continue Reading →

Are We Finally Reawakening to the Profound Healing Properties of Psychedelics?

June 18, 2012 MDMA

Legal research on a range of currently illegal drugs indicates they may help cure PTSD, alcoholism and even cluster headaches June 14, 2012  | Slowly but surely, we may be reaching success in a determined and long-time legal effort to unleash the curative powers of psychedelic drugs in America. There is a tremendous need for […]

Continue Reading →

Pure ecstasy can be ‘safe’ if consumed responsibly: B.C. health officer

June 14, 2012 Global Policy News

Tamsyn Burgmann, Thursday, June 14, 2012 4:35 AM Read it on Global News: Global News | Pure ecstasy can be ‘safe’ if consumed responsibly: B.C. health officer   VANCOUVER – B.C.’s top health official says taking pure ecstasy can be “safe” when consumed responsibly by adults, despite warnings by police in Alberta and British Columbia […]

Continue Reading →

Ecstasy and cannabis should be freely available for study, says David Nutt

May 31, 2012 Cannabis

Former government adviser says regulations make it too difficult to research psychoactive drugs with potential medical uses Alok Jha, science correspondent The Guardian, Thursday 31 May 2012 Ecstasy and cannabis should be freely available for study. The classification system that makes drugs such as cannabis and MDMA (ecstasy) illegal has prevented scientists from properly researching their possible therapeutic […]

Continue Reading →

MDMA for treating post traumatic stress disorder: 80% success rate. Beckley Foundation’s work on psilocybin also praised

July 8, 2011 Beckley Science in the Media

An article posted by Craig K. Comstock on the Huffington Post talks of the huge success of Michael Mithoefer’s study into the medicinal purposes of MDMA, in particular reference to treating post traumatic stress disorder (PTSD). After MDMA-assisted psychotherapy, 80% no longer met the diagnostic criteria for PTSD, as compared to only 25% in the […]

Continue Reading →